IP Library Granted Patent US 7,498,041
Granted Patent B2
US 7,498,041 · App. 11/247,230 · Granted Mar 3, 2009

Composition for repair of defects in osseous tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,498,041
App. No.
11/247,230
Granted
Mar 3, 2009
Kind
B2
Abstract

Tissue repair compositions, particularly bone repair compositions, containing demineralized bone fragments and homogenized connective tissues. The compositions can be used in the form of an injectable gel, an injectable paste, a paste, a putty, or a rehydratable freeze-dried form.

Claims (53)

1. A tissue repair composition comprising: a plurality of demineralized bone fragments and a carrier, wherein the carrier comprises at least one homogenized connective tissue.

2. The tissue repair composition of claim 1 , wherein the plurality of demineralized bone fragments and the homogenized connective tissue are prepared from bone and connective tissue obtained from a single source.

3. The tissue repair composition of claim 1 , wherein the plurality of demineralized bone fragments and the homogenized connective tissue are prepared from bone and connective tissue obtained from a single vertebrate source.

4. The tissue repair composition of claim 1 , wherein each of the plurality of demineralized bone fragments and the homogenized connective tissue are independently derived from at least one of a human source, a bovine source, an equine source, a porcine source, an ovine source, a caprine source and a piscene source.

5. The tissue repair composition of claim 1 , wherein the plurality of demineralized bone fragments comprises at least one of demineralized bone particles and demineralized bone fibers.

6. The tissue repair composition of claim 1 , wherein the plurality of demineralized bone fragments comprises demineralized, cortical bone particles.

7. The tissue repair composition of claim 1 , wherein the composition comprises demineralized bone fibers having an average thickness of between about 0.1 mm and about 0.3 mm and an average width of between about 0.3 mm and about 1.0 mm.

8. The tissue repair composition of claim 1 , wherein the plurality of demineralized bone fragments comprises demineralized, cancellous bone.

9. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have an average diameter of between about 125 microns and about 4 mm.

10. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have an average diameter of between about 125 microns and about 500 microns.

11. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have an average diameter of between about 125 microns and about 850 microns.

12. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have an average diameter of between about 250 microns and about 710 microns.

13. The tissue repair composition of claim 1 , wherein the plurality of demineralized bone fragments comprises at least one of demineralized allogenic cortical bone particles and demineralized xenogenic cortical bone particles.

14. The tissue repair composition of claim 1 , wherein the composition comprises between about 5 wt % and about 90 wt % demineralized bone fragments.

15. The tissue repair composition of claim 1 , wherein the composition comprises between about 20 wt % and about 80 wt % demineralized bone fragments.

16. The tissue repair composition of claim 1 , wherein the composition comprises between about 30 wt % and about 50 wt % demineralized bone fragments.

17. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have less than about 8 wt % residual calcium.

18. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have less than about 4 wt % residual calcium.

19. The tissue repair composition of claim 1 , wherein the demineralized bone fragments have between about 0.5 wt % and about 4 wt % residual calcium.

20. The tissue repair composition of claim 1 , wherein the carrier comprises at least one of homogenized fascia, homogenized tendon, homogenized ligament, homogenized pericardium, and homogenized articular cartilage.

21. The tissue repair composition of claim 1 , wherein the homogenized connective tissue is prepared by a homogenization method that results in shear-induced shredding of connective tissue.

22. The tissue repair composition of claim 1 , wherein the homogenized connective tissue is prepared by a method comprising heating unhomogenized connective tissue, and homogenizing the heated unhomogenized connective tissue.

23. The tissue repair composition of claim 1 , wherein the homogenized connective tissue is prepared by a method comprising at least one of (a) heating a connective tissue as it is homogenized and (b) heating a connective tissue homogenate.

24. The tissue repair composition of claim 1 , wherein the composition further comprises at least one of water, an aqueous solution, and a water miscible polar organic solvent.

25. The tissue repair composition of claim 1 , wherein the composition is a gel, a paste, or a putty.

26. The tissue repair composition of claim 1 , wherein the composition can be extruded through at least a 13 gauge or larger gauge syringe needle.

27. The tissue repair composition of claim 1 , wherein the composition is moldable.

28. The tissue repair composition of claim 1 , wherein the composition is sterile.

29. The tissue repair composition of claim 1 , wherein the composition is in a shaped form.

30. The tissue repair composition of claim 1 , further comprising a bioactive compound.

31. The tissue repair composition of claim 30 , wherein the bioactive compound is a growth factor.

32. The tissue repair composition of claim 31 , wherein the growth factor is a transforming growth factor beta, a fibroblast growth factor, a vascular endotheial growth factor, or a platelet derived growth factor.

33. The tissue repair composition of claim 30 , wherein the bioactive compound is a bone morphogenic protein or insulin.

34. A method of inducing bone formation comprising applying the tissue repair composition of claim 1 to an implant site to induce bone formation.

35. The method of claim 34 , wherein the implant site is in an animal.

36. The method of claim 34 , wherein the implant site is in a patient.

37. The method of claim 36 , wherein the tissue repair composition is an allogenic tissue repair composition.

38. The method of claim 36 , wherein the tissue repair composition is a xenogenic tissue repair composition.

39. The method of claim 36 , wherein the tissue repair composition comprises demineralized bone fragments and connective tissues prepared from a single source.

40. The method of claim 39 , wherein the source of the demineralized bone fragments and connective tissues, and the patient are the same species.

41. The method of claim 34 , wherein the tissue repair composition further comprises a bioactive compound.

42. The method of claim 41 , wherein the bioactive compound is a growth factor.

43. The method of claim 42 , wherein the growth factor is a transforming growth factor beta, a fibroblast growth factor, a vascular endothelial growth factor, or a platelet derived growth factor.

44. The method of claim 41 , wherein the bioactive compound is a bone morphogenic protein or insulin.

45. A method of promoting bone repair or regeneration comprising applying the tissue repair composition of claim 1 to a damaged bone tissue to promote repair or regeneration of the bone tissue.

46. The method of claim 45 , wherein the damaged bone tissue is in an animal.

47. The method of claim 45 , wherein the damaged bone tissue is in a patient.

48. The method of claim 47 , wherein the tissue repair composition is an allogenic tissue repair composition.

49. The method of claim 47 , wherein the tissue repair composition is a xenogenic tissue repair composition.

50. The method of claim 47 , wherein the tissue repair composition comprises demineralized bone fragments and connective tissues prepared from a single source.

51. The method of claim 50 , wherein the source of the demineralized bone fragments and connective tissues, ad the patient are the same species.

52. A method of coating a prosthetic device comprising providing a implantable prosthetic device and applying a tissue repair composition of claim 1 to at least a portion of the surface of the device.

53. A coated prosthetic device comprising a implantable prosthetic device coated with a tissue repair composition prepared by the method of claim 52 .

Assignments (8)
SECURITY INTEREST Recorded Apr 2, 2021
From: LIFENET HEALTH; SKIN AND WOUND ALLOGRAFT INSTITUTE, LLC
To: TRUIST BANK
Reel/Frame 055815/0623 →
RELEASE OF SECURITY INTEREST Recorded Jun 11, 2019
From: SUNTRUST BANK
To: LIFENET HEALTH; SKIN AND WOUND ALLOGRAFT INSTITUTE, LLC
Reel/Frame 049428/0001 →
SECURITY INTEREST Recorded Jun 10, 2019
From: LIFENET HEALTH; SKIN AND WOUND ALLOGRAFT INSTITUTE, LLC
To: SUNTRUST BANK
Reel/Frame 049424/0312 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 21, 2015
From: LIFENET HEALTH; SKIN AND WOUND ALLOGRAFT INSTITUTE, LLC
To: SUNTRUST BANK
Reel/Frame 037355/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2008
From: MASINAEI, LEILA; WOLFINBARGER, LLOYD, JR.
To: LIFENET HEALTH
Reel/Frame 021013/0828 →
CORRECTIVE COVER SHEET TO CORRECT PATENT APPLICATION NUMBERS D471,971 29/148,528 ON ASSIGNMENT PREVIOUSLY RECORDED AT REEL 020288 FRAME 0872. Recorded Jan 29, 2008
From: LIFENET
To: LIFENET HEALTH
Reel/Frame 020462/0781 →
CHANGE OF NAME Recorded Dec 20, 2007
From: LIFENET
To: LIFENET HEALTH
Reel/Frame 020288/0872 →
CHANGE OF NAME Recorded Nov 26, 2007
From: LIFENET
To: LIFENET HEALTH
Reel/Frame 020166/0991 →